Results 291 to 295 of about 58,085 (295)

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Journal of Clinical Oncology, 2018
Christina Lacchetti, Michael B Atkins, Ian Chau   +2 more
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah, Bettina Ryll, Razelle Kurzrock   +2 more
exaly  

Sitagliptin, a dipeptidyl peptidase‐4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline

Diabetes, obesity and metabolism, 2015
V. Gault, Rachael Lennox, P. R. Flatt
semanticscholar   +1 more source

Dipeptidyl peptidase-4 (DPP-4) inhibitors

British Journal of Cardiology, 2017
openaire   +1 more source

Chapter-07 Dipeptidyl Peptidase-4 Inhibitors

2014
openaire   +1 more source